EMERGENT BIOSOLUTIONS EXPANDS GLOBAL MARKETING REACH

Emergent BioSolutions today announced the opening of an office in Munich, Germany dedicated to the expansion of markets throughout Europe and Asia. The office will be headed by Dr. Andreas Hartmann, recently named Vice President International Markets for Emergent BioSolutions. Emergent BioSolutions, through its biodefense business unit, manufactures and markets BioThrax(R), the only FDA-approved vaccine for the prevention of anthrax.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-23-2005/0004093048&EDATE=)